Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets
NHS hospitals in England used £241,099,569 of indicative cost of Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets in the 12 months to July 2026, about 0.9% of all hospital medicines spend. That is down 3.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Chelsea & Westminster Hospital Nhs Ft | £75,630,617 |
| Manchester University Nhs Ft | £18,554,067 |
| Guy's & St Thomas' Nhs Foundation Trust | £11,182,505 |
| Western Sussex Hospitals Nhs Found Trust | £10,453,876 |
| Barts Health Nhs Trust | £9,519,645 |
| Univ Hpl B/Ham Nhs Foundation Trust | £8,431,180 |
| Aintree University Hospital Nhs Ft | £6,378,223 |
| Imperial College Healthcare Nhs Trust | £6,084,032 |
| Lewisham And Greenwich Nhs Trust | £4,748,103 |
| London North West Healthcare Nhs Trust | £4,221,809 |
The primary-care picture
Emtricitabine is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Emtricitabine medicine page.